| extraocular skeletal muscle development | GO:0002074 | 1 | 0.852 | Human |
| negative regulation of testicular blood vessel morphogenesis | GO:0061369 | 1 | 0.699 | |
| endocrine system development | GO:0035270 | 26 | 0.694 | Human |
| canonical wnt signaling pathway involved in mesenchymal stem cell differentiation | GO:0044338 | 2 | 0.685 | |
| positive regulation of epithelial cell proliferation involved in wound healing | GO:0060054 | 3 | 0.653 | |
| circulatory system development | GO:0072359 | 262 | 0.644 | |
| cardiovascular system development | GO:0072358 | 262 | 0.604 | |
| forebrain regionalization | GO:0021871 | 3 | 0.575 | |
| vasculature development | GO:0001944 | 181 | 0.505 | |
| organ formation | GO:0048645 | 3 | 0.505 | |
| tube development | GO:0035295 | 125 | 0.495 | Human |
| canonical wnt signaling pathway involved in osteoblast differentiation | GO:0044339 | 2 | 0.493 | |
| regulation of dermatome development | GO:0061183 | 3 | 0.484 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.459 | Human |
| mesonephric duct development | GO:0072177 | 3 | 0.455 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.453 | Human |
| negative regulation of developmental process | GO:0051093 | 247 | 0.450 | Human |
| organ morphogenesis | GO:0009887 | 147 | 0.449 | Human |
| dermatome development | GO:0061054 | 3 | 0.426 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.424 | Human |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.416 | |
| positive regulation of glucocorticoid biosynthetic process | GO:0031948 | 1 | 0.397 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.384 | |
| positive regulation of glucocorticoid metabolic process | GO:0031945 | 1 | 0.383 | |
| canonical wnt signaling pathway involved in cardiac muscle cell fate commitment | GO:0061317 | 3 | 0.380 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.374 | |
| cardiac cell fate determination | GO:0060913 | 3 | 0.360 | |
| positive regulation of cortisol biosynthetic process | GO:2000066 | 1 | 0.357 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.357 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.355 | Human |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.352 | |
| positive regulation of aldosterone metabolic process | GO:0032346 | 2 | 0.351 | |
| cartilage condensation | GO:0001502 | 1 | 0.347 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.336 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.332 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.324 | |
| skeletal system development | GO:0001501 | 79 | 0.318 | |
| regulation of locomotion | GO:0040012 | 329 | 0.304 | |
| specification of organ identity | GO:0010092 | 3 | 0.303 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.300 | Human |
| blood vessel development | GO:0001568 | 172 | 0.299 | |
| tube morphogenesis | GO:0035239 | 95 | 0.298 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.296 | |
| positive regulation of tooth mineralization | GO:0070172 | 2 | 0.294 | |
| epithelium development | GO:0060429 | 227 | 0.291 | |
| menstrual cycle phase | GO:0022601 | 2 | 0.288 | Human |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.287 | |
| stem cell differentiation | GO:0048863 | 93 | 0.283 | Human |
| neuron fate commitment | GO:0048663 | 2 | 0.281 | |
| positive regulation of odontogenesis | GO:0042482 | 3 | 0.280 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.279 | |
| stem cell development | GO:0048864 | 69 | 0.275 | Human |
| cellular amine metabolic process | GO:0044106 | 41 | 0.270 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.269 | |
| regulation of male gonad development | GO:2000018 | 4 | 0.267 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.262 | |
| regulation of cell migration | GO:0030334 | 289 | 0.257 | |
| nervous system development | GO:0007399 | 293 | 0.257 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.244 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.239 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.233 | |
| epithelial tube branching involved in lung morphogenesis | GO:0060441 | 4 | 0.232 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 4 | 0.232 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.227 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.226 | Human |
| digestive system development | GO:0055123 | 75 | 0.220 | Human |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.219 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.216 | Human |
| regulation of mapk cascade | GO:0043408 | 262 | 0.216 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.211 | |
| amine metabolic process | GO:0009308 | 44 | 0.208 | |
| mesenchyme development | GO:0060485 | 59 | 0.208 | Human |
| cell cell signaling | GO:0007267 | 155 | 0.205 | |
| mapk cascade | GO:0000165 | 288 | 0.202 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.200 | |
| immune system development | GO:0002520 | 195 | 0.199 | Human |
| regulation of canonical wnt signaling pathway | GO:0060828 | 88 | 0.199 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.199 | |
| negative regulation of male gonad development | GO:2000019 | 1 | 0.193 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.192 | Human |
| renal system development | GO:0072001 | 63 | 0.191 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.190 | |
| response to growth factor | GO:0070848 | 205 | 0.189 | |
| limb bud formation | GO:0060174 | 1 | 0.187 | |
| cell morphogenesis | GO:0000902 | 296 | 0.183 | Human |
| embryonic forelimb morphogenesis | GO:0035115 | 4 | 0.180 | |
| heart development | GO:0007507 | 95 | 0.177 | |
| positive regulation of mapk cascade | GO:0043410 | 190 | 0.176 | |
| regulation of cell motility | GO:2000145 | 299 | 0.175 | |
| cell fate determination | GO:0001709 | 3 | 0.173 | |
| system process | GO:0003008 | 349 | 0.171 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.170 | |
| wnt signaling pathway involved in wound healing spreading of epidermal cells | GO:0035659 | 1 | 0.170 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.169 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.169 | |
| mesenchymal cell development | GO:0014031 | 50 | 0.166 | Human |
| digestive tract development | GO:0048565 | 75 | 0.166 | Human |
| cell development | GO:0048468 | 328 | 0.165 | Human |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.162 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.162 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.161 | Human |
| positive regulation of aldosterone biosynthetic process | GO:0032349 | 2 | 0.160 | |
| cardiac right ventricle morphogenesis | GO:0003215 | 3 | 0.160 | |
| mesonephros development | GO:0001823 | 17 | 0.156 | |
| thymus development | GO:0048538 | 3 | 0.156 | Human |
| angiogenesis | GO:0001525 | 147 | 0.152 | |
| mesenchymal cell differentiation | GO:0048762 | 52 | 0.150 | Human |
| positive regulation of epithelial cell proliferation | GO:0050679 | 65 | 0.150 | |
| ossification | GO:0001503 | 121 | 0.149 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.147 | |
| gland development | GO:0048732 | 48 | 0.142 | Human |
| spinal cord development | GO:0021510 | 4 | 0.141 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 125 | 0.140 | |
| muscle tissue development | GO:0060537 | 62 | 0.138 | Human |
| regulation of protein serine threonine kinase activity | GO:0071900 | 179 | 0.137 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.137 | Human |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.135 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.135 | Human |
| formation of primary germ layer | GO:0001704 | 42 | 0.135 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.134 | |
| pituitary gland development | GO:0021983 | 2 | 0.134 | |
| forelimb morphogenesis | GO:0035136 | 4 | 0.133 | |
| forebrain generation of neurons | GO:0021872 | 3 | 0.130 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.130 | |
| urogenital system development | GO:0001655 | 65 | 0.129 | |
| osteoblast differentiation | GO:0001649 | 92 | 0.129 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.128 | |
| canonical wnt signaling pathway | GO:0060070 | 116 | 0.128 | |
| connective tissue development | GO:0061448 | 39 | 0.127 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.123 | |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.121 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.121 | Human |
| regulation of stem cell differentiation | GO:2000736 | 56 | 0.119 | Human |
| nephron morphogenesis | GO:0072028 | 15 | 0.119 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.119 | |
| post embryonic development | GO:0009791 | 2 | 0.118 | |
| somatic stem cell maintenance | GO:0035019 | 4 | 0.118 | |
| segmentation | GO:0035282 | 4 | 0.117 | Fly |
| skeletal system morphogenesis | GO:0048705 | 24 | 0.116 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.115 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.114 | Human |
| oxidative stress induced premature senescence | GO:0090403 | 3 | 0.114 | |
| central nervous system development | GO:0007417 | 123 | 0.113 | |
| regulation of hormone levels | GO:0010817 | 125 | 0.112 | |
| head development | GO:0060322 | 108 | 0.112 | Fly |
| positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation | GO:0003257 | 3 | 0.110 | |
| fibroblast growth factor receptor signaling pathway involved in mammary gland specification | GO:0060595 | 1 | 0.109 | |
| endodermal cell fate commitment | GO:0001711 | 4 | 0.109 | |
| striated muscle tissue development | GO:0014706 | 59 | 0.109 | Human |
| right ventricular cardiac muscle tissue morphogenesis | GO:0003221 | 2 | 0.108 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.108 | |
| positive regulation of dermatome development | GO:0061184 | 3 | 0.108 | |
| regulation of system process | GO:0044057 | 101 | 0.107 | |
| cell differentiation in spinal cord | GO:0021515 | 1 | 0.107 | |
| cloacal septation | GO:0060197 | 1 | 0.104 | |
| positive regulation of cellular component movement | GO:0051272 | 181 | 0.104 | |
| cardiac muscle tissue development | GO:0048738 | 39 | 0.104 | |
| forebrain development | GO:0030900 | 26 | 0.103 | |
| hindlimb morphogenesis | GO:0035137 | 2 | 0.103 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.103 | Human |
| digestive tract morphogenesis | GO:0048546 | 56 | 0.103 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.102 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.101 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.100 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 94 | 0.099 | |
| cell aggregation | GO:0098743 | 1 | 0.098 | |
| cell adhesion | GO:0007155 | 325 | 0.098 | |
| hair follicle morphogenesis | GO:0031069 | 2 | 0.097 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.097 | Human |
| response to wounding | GO:0009611 | 168 | 0.097 | Human |
| regulation of transferase activity | GO:0051338 | 355 | 0.096 | |
| cell proliferation in forebrain | GO:0021846 | 1 | 0.096 | |
| brain development | GO:0007420 | 97 | 0.095 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.094 | |
| generation of neurons | GO:0048699 | 152 | 0.094 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.094 | |
| heart morphogenesis | GO:0003007 | 48 | 0.092 | |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 0.092 | |
| positive regulation of hormone biosynthetic process | GO:0046886 | 4 | 0.092 | |
| secretion by cell | GO:0032940 | 226 | 0.091 | |
| secretion | GO:0046903 | 254 | 0.091 | |
| morphogenesis of an epithelium | GO:0002009 | 60 | 0.090 | |
| canonical wnt signaling pathway involved in negative regulation of apoptotic process | GO:0044336 | 2 | 0.089 | |
| kidney epithelium development | GO:0072073 | 25 | 0.089 | |
| neurogenesis | GO:0022008 | 169 | 0.089 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.088 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 227 | 0.088 | |
| mesonephric epithelium development | GO:0072163 | 14 | 0.086 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.086 | |
| regulation of secretion | GO:0051046 | 194 | 0.086 | |
| wound healing | GO:0042060 | 115 | 0.086 | Human |
| nephric duct development | GO:0072176 | 4 | 0.085 | |
| nephron epithelium development | GO:0072009 | 23 | 0.085 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.085 | |
| lipid metabolic process | GO:0006629 | 381 | 0.085 | |
| regulation of cell development | GO:0060284 | 161 | 0.084 | Human |
| ureteric bud development | GO:0001657 | 13 | 0.084 | |
| epithelial tube morphogenesis | GO:0060562 | 38 | 0.084 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.083 | |
| branch elongation involved in ureteric bud branching | GO:0060681 | 2 | 0.083 | |
| cell activation | GO:0001775 | 213 | 0.083 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.083 | |
| regulation of protein localization | GO:0032880 | 296 | 0.083 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 19 | 0.083 | |
| bud outgrowth involved in lung branching | GO:0060447 | 1 | 0.083 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.083 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.081 | |
| outflow tract septum morphogenesis | GO:0003148 | 4 | 0.080 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.080 | |
| hindbrain development | GO:0030902 | 3 | 0.080 | |
| biological adhesion | GO:0022610 | 331 | 0.079 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 55 | 0.079 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.079 | |
| actin filament based process | GO:0030029 | 224 | 0.079 | |
| ureteric bud morphogenesis | GO:0060675 | 10 | 0.079 | |
| bmp signaling pathway involved in heart development | GO:0061312 | 3 | 0.078 | |
| negative regulation of cellular component movement | GO:0051271 | 106 | 0.078 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.077 | |
| heart formation | GO:0060914 | 2 | 0.076 | |
| negative regulation of cell growth | GO:0030308 | 83 | 0.076 | |
| bmp signaling pathway | GO:0030509 | 49 | 0.076 | |
| cell growth | GO:0016049 | 160 | 0.076 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.075 | |
| response to lipid | GO:0033993 | 206 | 0.075 | Human |
| regulation of peptidase activity | GO:0052547 | 180 | 0.075 | Human |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.074 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.074 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.074 | Human |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.074 | |
| regulation of odontogenesis | GO:0042481 | 4 | 0.074 | |
| regulation of osteoblast differentiation | GO:0045667 | 38 | 0.074 | |
| forebrain neuron differentiation | GO:0021879 | 3 | 0.073 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.073 | |
| sex determination | GO:0007530 | 3 | 0.072 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.072 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.072 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.072 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.072 | |
| morphogenesis of a branching structure | GO:0001763 | 21 | 0.072 | |
| pattern specification process | GO:0007389 | 43 | 0.071 | Fly |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.071 | Human |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.071 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 45 | 0.070 | |
| regulation of organ morphogenesis | GO:2000027 | 24 | 0.069 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.069 | |
| positive regulation of transport | GO:0051050 | 336 | 0.069 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.069 | Human |
| positive regulation of cell motility | GO:2000147 | 177 | 0.068 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.068 | |
| mesodermal cell fate commitment | GO:0001710 | 2 | 0.067 | |
| tissue morphogenesis | GO:0048729 | 96 | 0.067 | |
| neuron differentiation | GO:0030182 | 138 | 0.066 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 205 | 0.065 | |
| small molecule biosynthetic process | GO:0044283 | 157 | 0.065 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.065 | |
| kidney morphogenesis | GO:0060993 | 19 | 0.065 | |
| regulation of small gtpase mediated signal transduction | GO:0051056 | 156 | 0.065 | |
| androgen biosynthetic process | GO:0006702 | 3 | 0.065 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 2 | 0.064 | |
| mesodermal cell fate specification | GO:0007501 | 2 | 0.064 | |
| male sex differentiation | GO:0046661 | 25 | 0.064 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.064 | |
| growth | GO:0040007 | 202 | 0.064 | |
| regulation of ras protein signal transduction | GO:0046578 | 155 | 0.064 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.063 | |
| taxis | GO:0042330 | 157 | 0.063 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.063 | |
| cardiocyte differentiation | GO:0035051 | 23 | 0.063 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 13 | 0.063 | |
| regulation of nucleotide catabolic process | GO:0030811 | 205 | 0.062 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.062 | |
| regulation of branching involved in ureteric bud morphogenesis | GO:0090189 | 3 | 0.062 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.062 | |
| motor neuron axon guidance | GO:0008045 | 2 | 0.062 | |
| organic hydroxy compound metabolic process | GO:1901615 | 147 | 0.061 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.061 | |
| embryonic camera type eye development | GO:0031076 | 2 | 0.061 | |
| sensory organ development | GO:0007423 | 52 | 0.060 | Human |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.060 | |
| nephron tubule morphogenesis | GO:0072078 | 13 | 0.060 | |
| regulation of body fluid levels | GO:0050878 | 99 | 0.060 | Human |
| positive regulation of cell migration | GO:0030335 | 172 | 0.060 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.060 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.060 | |
| regionalization | GO:0003002 | 29 | 0.060 | Fly |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.059 | Human |
| chemotaxis | GO:0006935 | 157 | 0.059 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 90 | 0.059 | |
| pharynx development | GO:0060465 | 1 | 0.059 | Human |
| cell cycle phase transition | GO:0044770 | 173 | 0.059 | |
| actin cytoskeleton organization | GO:0030036 | 207 | 0.059 | |
| ureteric bud elongation | GO:0060677 | 2 | 0.059 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.058 | |
| cerebellum development | GO:0021549 | 2 | 0.058 | |
| chromatin modification | GO:0016568 | 298 | 0.058 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.058 | |
| mesonephric tubule development | GO:0072164 | 14 | 0.058 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 186 | 0.058 | |
| cell projection organization | GO:0030030 | 252 | 0.057 | |
| positive regulation of cell cycle | GO:0045787 | 140 | 0.057 | Human |
| inner ear morphogenesis | GO:0042472 | 4 | 0.057 | |
| regulation of vasculature development | GO:1901342 | 97 | 0.057 | |
| embryo development | GO:0009790 | 123 | 0.056 | Fly |
| negative regulation of locomotion | GO:0040013 | 118 | 0.056 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 69 | 0.056 | |
| nephron epithelium morphogenesis | GO:0072088 | 15 | 0.056 | |
| cell fate commitment | GO:0045165 | 27 | 0.056 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 185 | 0.056 | |
| mesonephric tubule morphogenesis | GO:0072171 | 10 | 0.056 | |
| peptidyl tyrosine modification | GO:0018212 | 170 | 0.055 | |
| positive regulation of alcohol biosynthetic process | GO:1902932 | 9 | 0.055 | |
| metencephalon development | GO:0022037 | 2 | 0.055 | |
| muscle cell fate commitment | GO:0042693 | 4 | 0.055 | |
| cytokine production | GO:0001816 | 247 | 0.055 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.055 | Human |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.054 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.054 | Human |
| pulmonary vein morphogenesis | GO:0060577 | 1 | 0.054 | |
| renal tubule morphogenesis | GO:0061333 | 14 | 0.054 | |
| regulation of cytokine production | GO:0001817 | 232 | 0.054 | |
| cartilage development | GO:0051216 | 31 | 0.054 | |
| regulation of nervous system development | GO:0051960 | 88 | 0.053 | |
| hair cycle | GO:0042633 | 28 | 0.053 | |
| positive regulation of osteoblast differentiation | GO:0045669 | 23 | 0.053 | |
| response to transforming growth factor beta | GO:0071559 | 94 | 0.053 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 83 | 0.053 | Human |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.053 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.052 | |
| nuclear transport | GO:0051169 | 179 | 0.052 | |
| neuron development | GO:0048666 | 113 | 0.052 | |
| spemann organizer formation | GO:0060061 | 1 | 0.052 | |
| positive regulation of ossification | GO:0045778 | 32 | 0.052 | |
| regulation of cell adhesion | GO:0030155 | 166 | 0.051 | |
| negative regulation of cell migration | GO:0030336 | 102 | 0.051 | |
| negative regulation of cell development | GO:0010721 | 48 | 0.051 | Human |
| regulation of epithelial cell migration | GO:0010632 | 93 | 0.051 | |
| lipid biosynthetic process | GO:0008610 | 177 | 0.051 | |
| male gonad development | GO:0008584 | 23 | 0.050 | |
| regulation of nucleoside metabolic process | GO:0009118 | 209 | 0.050 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.050 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.050 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.049 | Human |
| chromatin organization | GO:0006325 | 351 | 0.049 | |
| ameboidal type cell migration | GO:0001667 | 135 | 0.049 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.048 | Human |
| single organism cellular localization | GO:1902580 | 332 | 0.048 | |
| cytoplasmic transport | GO:0016482 | 379 | 0.048 | |
| embryonic hindlimb morphogenesis | GO:0035116 | 2 | 0.048 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 94 | 0.048 | |
| metanephros development | GO:0001656 | 16 | 0.048 | |
| regulation of cell growth | GO:0001558 | 135 | 0.048 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.048 | Human |
| cranial nerve development | GO:0021545 | 4 | 0.047 | |
| tongue development | GO:0043586 | 1 | 0.047 | |
| regulation of secretion by cell | GO:1903530 | 177 | 0.047 | |
| rho protein signal transduction | GO:0007266 | 26 | 0.047 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.047 | |
| cardiac muscle cell fate commitment | GO:0060923 | 4 | 0.047 | |
| positive regulation of cytoskeleton organization | GO:0051495 | 83 | 0.047 | |
| epithelial cell migration | GO:0010631 | 119 | 0.047 | |
| ion homeostasis | GO:0050801 | 230 | 0.046 | |
| limbic system development | GO:0021761 | 3 | 0.046 | |
| regulation of gtp catabolic process | GO:0033124 | 180 | 0.046 | |
| regulation of muscle organ development | GO:0048634 | 27 | 0.046 | |
| nephron development | GO:0072006 | 30 | 0.046 | |
| response to cytokine | GO:0034097 | 232 | 0.046 | |
| neuroendocrine cell differentiation | GO:0061101 | 2 | 0.045 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.045 | Human |
| epidermis morphogenesis | GO:0048730 | 3 | 0.045 | |
| epithelium migration | GO:0090132 | 119 | 0.045 | |
| muscle structure development | GO:0061061 | 98 | 0.045 | Human |
| embryonic camera type eye formation | GO:0060900 | 2 | 0.044 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 9 | 0.044 | |
| cd8 positive alpha beta t cell differentiation involved in immune response | GO:0002302 | 1 | 0.044 | |
| regulation of protein transport | GO:0051223 | 213 | 0.044 | |
| regeneration | GO:0031099 | 4 | 0.044 | |
| oogenesis | GO:0048477 | 2 | 0.043 | |
| hemopoiesis | GO:0030097 | 180 | 0.043 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.043 | |
| tissue migration | GO:0090130 | 119 | 0.043 | |
| single organism cell adhesion | GO:0098602 | 179 | 0.043 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.043 | |
| aortic valve development | GO:0003176 | 3 | 0.043 | |
| cell fate commitment involved in formation of primary germ layer | GO:0060795 | 6 | 0.043 | |
| regulation of map kinase activity | GO:0043405 | 108 | 0.042 | |
| lymphocyte activation | GO:0046649 | 133 | 0.042 | |
| leukocyte activation | GO:0045321 | 164 | 0.042 | |
| guanosine containing compound catabolic process | GO:1901069 | 239 | 0.042 | |
| female gamete generation | GO:0007292 | 2 | 0.042 | |
| gtp metabolic process | GO:0046039 | 239 | 0.041 | |
| positive regulation of urothelial cell proliferation | GO:0050677 | 1 | 0.041 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 76 | 0.041 | |
| cell substrate adhesion | GO:0031589 | 132 | 0.041 | |
| kidney development | GO:0001822 | 53 | 0.041 | |
| bone development | GO:0060348 | 26 | 0.041 | |
| eye development | GO:0001654 | 42 | 0.041 | Human |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.041 | |
| alcohol metabolic process | GO:0006066 | 114 | 0.040 | |
| soft palate development | GO:0060023 | 3 | 0.040 | Human |
| negative regulation of mitotic cell cycle | GO:0045930 | 102 | 0.040 | Human |
| regulation of cardioblast differentiation | GO:0051890 | 4 | 0.040 | |
| activation of mapk activity | GO:0000187 | 45 | 0.040 | |
| guanosine containing compound metabolic process | GO:1901068 | 244 | 0.040 | |
| regulation of response to wounding | GO:1903034 | 101 | 0.040 | Human |
| endochondral bone morphogenesis | GO:0060350 | 3 | 0.040 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.040 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 48 | 0.040 | |
| regulation of actin filament based process | GO:0032970 | 141 | 0.039 | |
| positive regulation of cytokine production | GO:0001819 | 167 | 0.039 | |
| regulation of intracellular protein transport | GO:0033157 | 123 | 0.039 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.039 | |
| odontogenesis | GO:0042476 | 25 | 0.039 | Human |
| stress activated mapk cascade | GO:0051403 | 93 | 0.039 | |
| positive regulation of male gonad development | GO:2000020 | 3 | 0.039 | |
| mesenchymal to epithelial transition involved in metanephros morphogenesis | GO:0003337 | 4 | 0.039 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 71 | 0.039 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.039 | |
| regulation of striated muscle tissue development | GO:0016202 | 26 | 0.039 | |
| protein maturation | GO:0051604 | 233 | 0.039 | |
| appendage morphogenesis | GO:0035107 | 16 | 0.039 | |
| lung associated mesenchyme development | GO:0060484 | 1 | 0.039 | |
| neuron projection development | GO:0031175 | 106 | 0.039 | |
| calcium ion transport | GO:0006816 | 147 | 0.038 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.038 | |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.038 | |
| immune response | GO:0006955 | 307 | 0.038 | |
| regulation of cell activation | GO:0050865 | 125 | 0.038 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.037 | |
| blastoderm segmentation | GO:0007350 | 2 | 0.037 | Fly |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.037 | |
| regulation of lipid biosynthetic process | GO:0046890 | 47 | 0.037 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.037 | |
| morphogenesis of a branching epithelium | GO:0061138 | 20 | 0.037 | |
| regulation of heart induction by regulation of canonical wnt signaling pathway | GO:0090081 | 1 | 0.037 | |
| positive regulation of gtp catabolic process | GO:0033126 | 166 | 0.037 | |
| positive regulation of protein transport | GO:0051222 | 135 | 0.037 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 79 | 0.036 | Human |
| positive regulation of map kinase activity | GO:0043406 | 80 | 0.036 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 170 | 0.036 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.036 | |
| positive regulation of keratinocyte migration | GO:0051549 | 4 | 0.036 | |
| cell projection morphogenesis | GO:0048858 | 129 | 0.036 | |
| cell cycle arrest | GO:0007050 | 71 | 0.036 | |
| regulation of growth | GO:0040008 | 165 | 0.036 | |
| menstruation | GO:0042703 | 1 | 0.036 | Human |
| regulation of ossification | GO:0030278 | 58 | 0.036 | |
| renal tubule development | GO:0061326 | 19 | 0.035 | |
| muscle organ development | GO:0007517 | 56 | 0.035 | Human |
| negative regulation of kidney development | GO:0090185 | 2 | 0.035 | |
| peripheral nervous system development | GO:0007422 | 2 | 0.035 | |
| nucleocytoplasmic transport | GO:0006913 | 176 | 0.035 | |
| blood circulation | GO:0008015 | 113 | 0.035 | |
| cellular homeostasis | GO:0019725 | 196 | 0.035 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.035 | |
| response to organonitrogen compound | GO:0010243 | 156 | 0.035 | |
| positive regulation of proteolysis | GO:0045862 | 142 | 0.035 | Human |
| regulation of gtpase activity | GO:0043087 | 180 | 0.035 | |
| negative regulation of gliogenesis | GO:0014014 | 3 | 0.034 | |
| blood coagulation | GO:0007596 | 76 | 0.034 | Human |
| hard palate development | GO:0060022 | 1 | 0.034 | Human |
| neurological system process | GO:0050877 | 163 | 0.034 | |
| epithelial to mesenchymal transition | GO:0001837 | 48 | 0.034 | Human |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.034 | |
| gastrulation | GO:0007369 | 51 | 0.034 | |
| positive regulation of gtpase activity | GO:0043547 | 166 | 0.034 | |
| divalent inorganic cation transport | GO:0072511 | 158 | 0.034 | |
| chemical homeostasis | GO:0048878 | 306 | 0.033 | |
| epithelial cell development | GO:0002064 | 34 | 0.033 | |
| transmembrane transport | GO:0055085 | 399 | 0.033 | |
| negative regulation of cell adhesion | GO:0007162 | 64 | 0.033 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.033 | Human |
| steroid metabolic process | GO:0008202 | 94 | 0.033 | |
| anterior posterior axis specification | GO:0009948 | 2 | 0.033 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 37 | 0.033 | Human |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.033 | |
| nerve development | GO:0021675 | 4 | 0.033 | |
| cardiac ventricle formation | GO:0003211 | 2 | 0.033 | |
| intracellular receptor signaling pathway | GO:0030522 | 104 | 0.033 | Human |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.033 | |
| protein localization to organelle | GO:0033365 | 280 | 0.033 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.032 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.032 | |
| neuromuscular junction development | GO:0007528 | 3 | 0.032 | |
| regulation of lipid metabolic process | GO:0019216 | 96 | 0.032 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.032 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 69 | 0.032 | Human |
| activation of protein kinase activity | GO:0032147 | 90 | 0.032 | |
| reproductive system development | GO:0061458 | 56 | 0.032 | Human |
| jnk cascade | GO:0007254 | 80 | 0.032 | |
| single organism reproductive process | GO:0044702 | 98 | 0.032 | Human |
